FDA Warning Letter — Prestige Brands Holdings
The FDA took a Warning Letter action against Prestige Brands Holdings on June 1, 2017 (Tarrytown, NY). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Prestige Brands Holdings
- Date
- June 1, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- Tarrytown, NY (United States)